| Literature DB >> 31133002 |
Susan Gordon1,2, Michael Kidd3,4, Anthony Maeder5, Nicky Baker6, Tania Marin6, Karen Grimmer6.
Abstract
BACKGROUND: Middle and older years are associated with age related health deficits but how early this begins and progresses is poorly understood. Better understanding is needed to address early decline and support healthier ageing outcomes.Entities:
Keywords: Health status; Healthy ageing; Normal values; Screening assessments
Year: 2019 PMID: 31133002 PMCID: PMC6537146 DOI: 10.1186/s12877-019-1152-9
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Health screening measurements, source of population norm data, compliance with population norms, and age and gender effects on non-compliance. An OR less than 1 indicates that males are more likely than females to have the outcome and an OR greater than 1 indicates that females are more likely to have the outcome than males
| Measure | Non-compliant | Independent age group effect | Independent gender effect | Age and gender subgroups |
|---|---|---|---|---|
| (OR 95% CI) | (OR 95% CI) | (OR 95% CI) | ||
| Comparator 40–49 y | Comparator Female | Comparator Female 40-49y | ||
| Overweight or obese* | 338 (61.1) | 40-49y OR = 1 | 0.7 (0.5–1.0) | |
| BMI 25–29.9 (overweight), 30+ (obese) [ |
| |||
|
| ||||
|
| ||||
| Waist-hip ratio | 298 (53.1) | 40-49y OR = 1 | 0.2 (0.1–0.3) | Compared with F 40-49y: |
|
| M40-49y 0.2 (0.07–0.4) | |||
| High risk: > 0.90 for males; > 0.85 for females [ | 60-69y 1.0 (0.6–1.7) | M50-59y 0.3 (0.1–0.5) | ||
| 70 + y 1.1 (0.7–3.9) | M60-69y 0.6 (0.3–0.3) | |||
| Physical activity* (see Footnote for description) | 293 (52.9) | No significant age effects | 1.5 (1.1–2.1) | |
| Blood Glucose 3.0–7.7 mmol/L [ | 216 (38.5) | No significant age effects | No significant gender effects | |
| Audiology* | 188 (33.9) | 40-49y OR = 1 | 0.6 (0.4–0.9) | Compared with F40-49y: |
| 7 or 8 = pass [ |
| F 50-59y 3.1 (1.2–8.1) | ||
|
| F 60-69y 6.0 (2.4–15.1) | |||
|
| F 70 + y 7.3 (2.9–18.6) | |||
| M 60-69y 20.0 (7.3–54.5) | ||||
| M 70 + y 8.4 (2.8–24.9) | ||||
| Waist circumference* | 185 (33.4) | No significant age effects | 2.1 (1.4–3.2) | Compared with F 40-49y: |
| High risk: females: ≥ 88 cm | M 40-49y 0.04 (0.01–0.1) | |||
| males: ≥102 cm or more [ | M 50-59y 0.1 (0.05–0.3) | |||
| M 60-69y 0.14 (0.1–0.3) | ||||
| M70 + y 0.1 (0.05–0.2) | ||||
| Cognition and memory* | 179 (32.3) | No significant age effects | No significant gender effects | |
| GPCog <=8 [ | ||||
| Blood pressure* | 164 (29.6) | 40-49y OR = 1 | No significant gender effects | Compared with F 40-49y: |
| 90-140 mmHg systolic, 60-90 mmHg diastolic [ | 50-59y 1.3 (0.7–2.3) | F 70 + y 2.5 (1.2–5.3) | ||
| 60-69y 1.5 (0.9–2.5) | M 60-69y 2.7 (1.2–6.1) | |||
|
| ||||
| Mobility* | 140 (25.3) | 40-49y OR = 1 | 1.4 (1.0–2.2) | Compared with F 40-49y: |
| Six Minute Walk Test (6MWT) | 50-59y 1.3 (0.8–3.1) | F 70 + y 4.1 (1.8–8.9) | ||
| 6MWDm = 518.853 + (1.25 x height in cm) – (2.816 x age in years) – (39.07 x sex men = 0; women = 1) [ |
| |||
|
| ||||
| Foot sensation* | 123 (22.6) | 40-49y OR = 1 | 0.6 (0.4–0.9) | Compared with F 40-49y: |
| Mono-filament testing All 20 correct responses (10 each foot) [21 |
| F 60-69y 3.6 (1.3–9.9) | ||
|
| F 70 + y 4.2 (1.5–11.6) | |||
|
| M 50-59y 4.0 (1.6–12.8) | |||
| M 60-69y 4.8 (1.6–14.1) | ||||
| M 70 + y 10.2 (3.2–32.4) | ||||
| Perceived exertion* | 115 (20.5) | No significant age effects | No significant gender effects | |
| Borg Exertion Scale | ||||
| scale 6–20, at-risk values> 13 [ | ||||
| Sleep quality* | 113 (20.4) | No significant age effects | No significant gender effects | |
| Pittsburgh Sleep Quality Index)(PSQI) ≥ 8 [ | ||||
| Lung capacity* | 82 (14.8) | No significant age effects | No significant gender effects | Compared with F 40-49y) |
| FEV1, FVC Normative tables for age and gender see [ | M 40-49y 3.9 (1.3–11.9) | |||
| M 50-59y 3.9 (1.2–12.3) | ||||
| Dexterity* | 82 (14.4) | No significant age effects | No significant gender effects | |
| The Purdue Dexterity Test norms see [ | ||||
| Grip strength* (dominant hand) Hand held dynamometer | 74 (13.4) | No significant age effects | No significant gender effects | |
| At-risk is in lowest 20th% of gender-age distribution [ | ||||
| Respiratory rate* | 17 (13.1) | No significant age effects | No significant gender effects | |
| 12–20 breaths/min [ | ||||
| Oximetry* | 36 (6.5) | 40-49y OR = 1 | No significant gender effects | |
| < 96% [ | 50-59y 6.1 (0.73–50.3) | |||
| 60-69y | ||||
|
| ||||
| K10 Psychological Distress* | 32 (5.8) | No significant age effects | No significant gender effects | |
| ≥ 13 [ | ||||
| Dyspnoea | 8 (1.4) | No significant age effects | No significant gender effects | |
| Borg Dyspnoea Scale At-risk values > 4 [ | ||||
| Temperature | 3 (0.5) | No significant age effects | No significant gender effects | |
| 35.5–37.5 degrees C [ | ||||
| Heart rate | 4 (0.4) | No significant age effects | No significant gender effects | |
| 60–100 beats per min [ |
Key: Significant differences between expected compliance and percentage of non-compliant scores (p < 0.05) identified by* after each measure; significant age group effects identified by italics: CI confidence interval, F female, M male, OR odds ratio, y years
Footnote: Active Australia Survey 18–65 year olds at risk: < 150 to 300 min (2 ½ to 5 h) moderate intensity physical activity, or 75 to 150 min (1 ¼ to 2 ½ hours) of vigorous intensity physical activity, or combination of both, each week. 65+ years at-risk: < 30 min moderate intensity physical activity on most days [14, 15]
Gender differences and mean age for number of deficits
| Deficits | %Males | %Females | mean age (SD) |
|---|---|---|---|
| 1 | 0 | 0.3 | 60 (0) |
| 2 | 0.6 | 2.2 | 55.7 (11.6) |
| 3 | 4.7 | 7.7 | 56.0 (9.9) |
| 4 | 7 | 15.3 | 59.9 (11.9) |
| 5 | 15.2 | 20.8 | 61.6 (9.9) |
| 6 | 12.9 | 20.8 | 60.7 (9.9) |
| 7 | 18.1 | 15.6 | 59.3 (9.8) |
| 8 | 18.1 | 10.1 | 60.0 (9.9) |
| 9 | 11.7 | 3.6 | 60.0 (10.1) |
| 10 | 7.6 | 1.9 | 62.3 (6.7) |
| 11 | 1.7 | 0.8 | 60.8 (4.5) |
| 12 | 1.7 | 0.6 | 55.0 (12.6) |
| 13 | 0.6 | 0 | 49 (0) |
SD standard deviation
Fig. 1Mean number of deficits by age and gender. F=Female, M = Male>